Two substituted quinazolinyl/imidazolyl-salicylic acids 5, 6 were synthesized by the reaction of 6-iodo-2-methylbenzoxazin-4-one/5-nitroimidazole with 5-aminosalicylic acid (5-ASA). Coupling of compounds 5 and 6 with different amino acid ester hydrochlorides, dipeptide and tripeptide methyl esters yielded novel quinazolino/imidazolopeptide derivatives 5a-f and 6a-g. The chemical structures of all newly synthesized compounds were confirmed by means of FT-IR, 1 H-and 13 C-NMR, MS and elemental analysis. Selected peptide ester derivatives were further hydrolyzed by using lithium hydroxide (LiOH) to afford the corresponding acid derivatives 5b a -d a and 6e a -g a . All peptide derivatives were assayed for antimicrobial and anthelmintic activities against eight pathogenic microbes and three earthworm species. Among the tested compounds, 5e, 5d, 6e and their hydrolyzed analogs 5d a and 6e a exhibited higher antimicrobial activity against Pseudomonas aeruginosa, Klebsiella pneumoniae and Candida albicans, and 5a, 6g and 6g a displayed better antifungal activity against the dermatophytes Trichophyton mentagrophytes and Microsporum audouinii. Moreover, 6f and its hydrolyzed derivative 6f a showed good anthelmintic activity against Megascoplex konkanensis, Pontoscotex corethruses and Eudrilus eugeniea at dose of 2 mg mL -1 .
Introduction
During past decades, compounds bearing heterocyclic nuclei have received much attention due to their chemotherapeutic value in the development of novel antimicrobials and anthelmintics. Quinazolinone and imidazole analogs are associated with a variety of pharmacological activities including antibacterial and antifungal [1] [2] [3] , anti-inflammatory and analgesic [4] [5] [6] , antitubercular [7, 8] , cytotoxic [9] [10] [11] , antiviral [12, 13] , anticonvulsant [14] , antimuscarinic [15] , insecticidal [16] , farnesyltransferase, gastric H + /K + -ATPase and MAP kinase p38 inhibitory properties [17] [18] [19] . Furthermore, the literature is enriched with several findings indicating antimicrobial potential of salicylic acid and its analogs [20] [21] [22] .
Prompted by the chemotherapeutic importance of quinazolinones/imidazoles and salicylic acid derivatives, these two vital moieties were combined together into a single molecule by varying the substitution pattern on heterocyclic moieties to yield 2-hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoic acid (5) and 2-hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoic acid (6) .
The literature contains several reports on the incorporation of amino acids and peptides into the aromatic and heterocyclic congeners resulting in compounds with potent bioactivities [23] [24] [25] [26] [27] . Thus, keeping in mind the pharmacological potential of quinazolinones/imidazoles/salicylic acids as well as taking advantage of biodegradability and biocompatibility of amino acids/peptides and further, in continuation of our earlier work on synthesis of bioactive peptide analogs of aroylbenzoic acids, aryloxyacetic acids, benzimidazoles and furoic acid [28] , an attempt was made towards the synthesis of two novel series of peptidyl derivatives of the iodoquinazolinones/nitroimidazoles -2-hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl amino acids/peptides 5a-f and 2-hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoyl amino acids/peptides 6a-g. Selected peptide derivatives were further hydrolyzed to get corresponding acid derivatives 5b a -d a and 6e a -g a . The potential antibacterial, antifungal and anthelmintic activities of the synthesized compounds were also evaluated.
Results and Discussion
6-Iodo-2-methylbenzoxazin-4-one (1a) was prepared in good yield according to a literature procedure [16] by refluxing of 5-iodoanthranilic acid and acetic anhydride with stirring. Imidazole was nitrated using nitrating mixture by the standard procedure [29] to afford 5-nitroimidazole (1b). Dipeptides Boc-Pro-Val-OMe (2a), Boc-Leu-Phe-OMe (2b), Boc-His-Phe-OMe (2c), Boc-Gly-GlyOMe (2d), Boc-Ile-Tyr-OMe (2e), Boc-Phe-Pro-OMe (2f) were prepared by coupling Boc-amino acids with the respective amino acid methyl ester hydrochlorides using dicyclohexylcarbodiimide (DCC) as coupling agent and triethylamine (TEA) as base, according to the Bodanzsky and Bodanzsky procedure with suitable modifications [30] . Similarly, tripeptides Boc-Ala-Pro-Try-OMe (3a), Boc-Gly-Leu-His-OMe (3b) and tetrapeptide Boc-Val-Tyr-Phe-Gly-OMe (4a) were synthesized by coupling Boc-dipeptides with respective amino acid methyl ester hydrochlorides/dipeptide methyl esters under alkaline conditions. Prior to coupling, all di-/tri-and tetrapeptides were deprotected at the amino end using trifluoroacetic acid (TFA). Compound 5 was prepared by the reaction of 1a and 5-ASA in ethanol, whereas compound 6 was synthesized by stirring 1b with a solution of diazotized 5-ASA. Finally, compound 5 was coupled with different amino acid methyl ester hydrochlorides and peptide methyl esters using DCC and N-methylmorpholine (NMM) in THF to afford peptide derivatives 5a-f. Similarly, coupling of compound 6 with different peptide methyl esters in the presence of DCC and TEA in DMF afforded amino acid/peptide conjugates 6a-g. Furthermore, amino acid/peptide derivatives 5b-d and 6e-g were hydrolyzed by stirring with LiOH to yield corresponding acid derivatives 5b a -d a and 6e a -g a (Scheme 1). All peptide derivatives 5a-6g a were synthesized in good yields using DCC as coupling agent and TEA/NMM as bases. Presence of bands at 3365-3362, 3305-2505, 1702-1697, 1542, 1349, 590 cm -1 in the IR spectra of compounds 5 and 6 clearly indicated presence of functional groups like -COOH, -OH, -NO 2 and -I and the absence of a free -NH 2 group which was present in the starting material 5-ASA. Furthermore, the IR spectra of peptide derivatives 5a-6g showed amide I and amide II bands at 1660-1637 cm -1 and 1538-1525 cm -1 , indicating formation of peptide bonds and confirming the success of the coupling reactions. This fact was further supported by the appearance of broad singlets for imino proton of the CO-NH moiety at 8.62-6.50 ppm in the 1 H-NMR spectra and singlets at 177.3-166.2 ppm (for the carbonyl carbon of the CO-NH moiety) in the 13 C-NMR spectra of compounds 5a−6g. Moreover, the presence of a NO 2 group in the peptide analogs of compound 6 was indicated by appearance of medium bands at 1544-1540 cm -1 and 1349-1345 cm -1 (asymmetric and symmetric NO 2 stretching) in the IR spectra, whereas presence of a iodo group in the peptide derivatives of compound 5 was indicated by the appearance of medium intensity bands at 592-587 cm -1 (C-I str ) in the IR spectra.
The mass spectra of peptide ester derivatives showed molecular ion peaks along with isotopic peaks at m/z values consistent with their respective molecular formulas. ] fragment ion peak appeared at m/z value 45 in the mass spectra of compounds 6f a and 6g a , along with characteristic fragmentation patterns on both sides of the carbonyl moiety. The newly synthesized compounds were also analyzed for C, H and N content and the results revealed deviations of ± 0.04 from calculated values.
Almost all the synthesized compounds were found to exhibit moderate to good bioactivity against Gram negative bacteria, dermatophytes and C. albicans. However, 5b-6g a displayed mild to moderate activity against Gram positive bacteria and A. niger. Comparison of the antimicrobial activity data suggested that the hydrolyzed peptide derivatives 5b a -d a and 6e a -g a are more potent antimicrobial agents than their corresponding methyl ester derivatives 5b-6g, but the methyl ester analogs were found to be more potent than the corresponding acid derivatives against dermatophytes.
Compounds 5a, 5d, 5d a , 5e, 6e, 6g, 6g a and 6e a were found to be the most active compounds, with higher antimicrobial activity against P. aeruginosa, K. pneumoniae, C. albicans and dermatophytes. Against Gram positive bacteria and A. niger, only compounds 5a, 5f and 6c exhibited significant activity in comparison to reference drugs -ciprofloxacin and griseofulvin respectively (Table 1, Figure  1) . (25) 8 (25) 14(12.5) 10(6) 6d
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14 (25) 11 (50) 26 (6) 21(12.5) 23 (6) 11 (6) 13 (25) 13 (6) 6f 15 (50) 12 (25) 20 (6) (25) 17 (6) 23 (6) 15 (50) 25 ( (6) 17 (6) 18 ( All imidazolopeptide derivatives 6a-g a showed moderate to good anthelmintic activity at 2 mg mL −1 concentration in Tween 80 (0.5 %) and distilled water, whereas quinazolinopeptide analogs 5a-d a displayed mild to moderate activity. Comparison of anthelmintic activity data revealed that hydrolyzed peptide derivatives 5b a -6g a are slightly more active than their corresponding ester derivatives 5b-6g. Compound 6f and its hydrolyzed derivative 6f a were found to exhibit higher bioactivity against all three earthworm species, in comparison to the standard drug -mebendazole. Compounds 6d, 6g and 6g a showed good anthelmintic activity whereas compounds 6a-c, 6e and 6e a displayed only moderate level of activity. Among quinazolinopeptides, no compound exhibited any significant anthelmintic activity except moderate activity for compounds 5e, 5b and its hydrolyzed derivative 5b a (Table 2, Figure 2 ).
Conclusions
The present study reports the successful synthesis of the title compounds in good yields via coupling reactions. For peptide coupling, the method employing DCC/TEA in DMF solvent proved to be better than the DCC/NMM method utilizing THF as solvent, providing 10-15 % additional yields. Gram negative bacteria proved to be more sensitive in comparison to Gram positive bacteria towards newly synthesized peptide derivatives. Greater anthelmintic activity was found in derivatives with histidine and tyrosine constituents in their amino acid chain. Hydrolyzed derivatives exhibited more antimicrobial and anthelmintic activity in comparison to their corresponding methyl ester derivatives except against dermatophytes. Among the tested compounds, 5a, 5d, 5d a , 5e, 5f, 6c, 6g, 6g a , 6e and 6e a showed good antimicrobial activity and, 6f and 6f a exhibited better anthelmintic activity. On passing toxicity tests, these compounds may prove good candidates for clinical studies and may be potential antimicrobial and anthelmintic agents of future.
Experimental

General
Melting points were determined by the open capillary method and are uncorrected. L-Amino acids, di-tert-butylpyrocarbonate (Boc 2 O), dicyclohexylcarbodiimide (DCC), trifluoroacetic acid (TFA), triethylamine (TEA) and N-methylmorpholine (NMM) were procured from Spectrochem Limited (Mumbai, India). IR spectra were recorded on a Shimadzu 8700 FTIR spectrophotometer using a thin film supported on KBr pellets or chloroform solutions.
1 H-NMR and 13 C-NMR spectra were recorded on Bruker AC NMR spectrometer (300 MHz) using CDCl 3 as solvent and TMS as internal standard. The mass spectra were recorded on a JMS-DX 303 mass spectrometer (Jeol, Tokyo, Japan) operating at 70 eV using the electron spray ionization technique (ESI MS). Optical rotation of synthesized peptide derivatives was measured on automatic polarimeter in a 2 dm tube at 25 °C using sodium lamp and methanol as solvent. Elemental analyses of all compounds were performed on Vario EL III elemental analyzer. Purity of all synthesized compounds was checked by TLC on precoated silica gel G plates utilizing chloroform/methanol in different ratios (9:1 / 7:3 v/v) as developing solvent system and spots were detected on exposure to iodine vapours in a tightly closed chamber. Compounds 3a, 3b and 4a were synthesized by coupling Boc-dipeptides with respective amino acid methyl ester hydrochlorides/dipeptide methyl esters under alkaline conditions. 
tert-Butyloxycarbonyl-alanyl-prolyl-tryptophan methyl ester (3a
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoic acid (5)
Equimolar amounts (0.025 mol) of 6-iodo-2-methylbenzoxazin-4-one (1a, 7.18 g) and 5-ASA 
2-Hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoic acid (6)
A mixture of 5-ASA (7.65 g), dilute hydrochloric acid (15%, 30 mL) and water (45 mL) was heated to give a clear solution. After cooling to 0 °C, the solution was diazotized by addition of sodium nitrite solution (30%, 12 mL). To the filtrate of diazotized salt solution, 5-nitroimidazole (1b, 5.65 g) and aqueous cupric chloride solution (1.3 g in 5 mL water) were added with stirring, followed by slow addition of water (25 mL), maintaining the temperature between 5-10 °C. Stirring was continued for 6 h and finally the reaction mixture was kept overnight in the refrigerator. The separated solid was collected by filtration and washed with cold water. The crude product was recrystallized from acetone to give a 77 % yield of pure 6 as a pale-yellow solid; m.p. 
General procedure for synthesis of amino acid / peptide derivatives of 2-hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoic acids 5a-f
Amino acid methyl ester hydrochloride/di/tri/tetrapeptide methyl ester (0.01 mol) was dissolved in THF (75 mL). To this, NMM (2.3 mL) was added at 0 °C and the reaction mixture was stirred for 15 min. Compound 5 (4.22 g, 0.01 mol) in THF (75 mL) and DCC (2.1 g) were added to the above mixture with stirring. After 36 h, the reaction mixture was filtered and the residue was washed with THF (25 mL). Then, filtrate was washed with 5% NaHCO 3 and saturated NaCl solutions (15 mL). The organic layer was dried over anhydrous Na 2 SO 4 , filtered and evaporated in vacuum. The crude product was recrystallized from a mixture of chloroform and n-hexane followed by cooling at 0 °C. 
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl nitro(arginine) methyl ester
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl tyrosine methyl ester (5b
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl prolyl-valine methyl ester
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl leucyl-phenylalanine methyl ester (5d)
.
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl-histidinyl-phenylalanine methyl ester (5e)
General procedure for synthesis of amino acid/peptide derivatives of 2-hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoic acids 6a-g
To a mixture of amino acid methyl ester hydrochloride/di/tri/tetrapeptide methyl ester (0.01 mol) in DMF (50 mL), TEA (2.8 mL) was added at 0 °C with stirring. Compound 6 (2.5 g, 0.01 mol) in DMF (50 mL) and DCC (2.1 g) were added to the above mixture and stirring was done for 24 h. After 24 h, the reaction mixture was filtered. To the filtrate, water was added in equal proportions and the aqueous layer was washed with ether (3 × 50 mL). The organic layer was separated and dried over anhydrous Na 2 SO 4 , filtered and evaporated under vacuum. The product obtained was dissolved in chloroform, washed with 10 % HCl, saturated NaHCO 3 solution and water (25 mL each) followed by evaporation under vacuum. The crude product was recrystallized from a mixture of ethyl acetate and petroleum ether. (6) To a solution of the amino acid / peptide methyl ester (0.01 mol) in THF-H 2 O (1:1, 36 mL), LiOH (0.36 g) was added at 0 °C. The mixture was stirred at RT for 1 h and then acidified to pH 3.5 with 1N H 2 SO 4 . The aqueous layer was extracted with Et 2 O (3 × 25 mL). The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The crude products were recrystallized from methanol and ether to afford hydrolyzed peptide derivatives 5b a -d a and 6e a -g a . solvents DMF/DMSO were used as negative controls and ciprofloxacin/griseofulvin were used as standards. Diameters of the zones of inhibition (in mm) were measured and the average diameters for test sample were calculated for triplicate sets. The diameters obtained for the test sample were compared with that produced by the standard drug -ciprofloxacin. The antibacterial study results are presented in Table 1 .
2-Hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoyl threonine methyl ester (6a
2-Hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoyl proline methyl ester (6b
2-Hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoyl isoleucyl-tyrosine methyl ester (6d
General method for hydrolysis of amino acid /peptide derivatives of 2-hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoic acid (5) / 2-hydroxy-5-(5-nitro-1H-imidazol-2-yl)benzoic acid
2-Hydroxy-5-(6-iodo-2-methyl-4-oxo-3,4-dihydro-3-quinazolinyl)benzoyl tyrosine (5b a
)
Anthelmintic activity
Anthelmintic activity studies were carried out against three different species of earthworms: Megascoplex konkanensis (ICARBC 211), Pontoscotex corethruses (ICARBC 117) and Eudrilus eugeniea (ICARBC 042) at 2 mg mL −1 concentration following Garg's method [32] . Tween 80 (0.5%) in distilled water was used as control and mebendazole was used as a reference compound. The paralysis and death times were noted and their mean was calculated for triplicate sets. The death time was ascertained by placing the earthworms in warm water (50 °C) which stimulated the movement, if the worm was alive. The anthelmintic study results are tabulated in Table 2 .
